Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by IL23 is a member of the interleukin 1 cytokine family. Additionally we are shipping Interleukin 23 Kits (86) and Interleukin 23 Proteins (16) and many more products for this protein.
Showing 10 out of 74 products:
Human Polyclonal IL23 Primary Antibody for IF (p), IHC (p) - ABIN673179
Yang, Gao, Shi, Zhou, Qu, Xu, Shan, Teng: Effect of iodine excess on Th1, Th2, Th17, and Treg cell subpopulations in the thyroid of NOD.H-2h4 mice. in Biological trace element research 2014
Show all 3 Pubmed References
Human Polyclonal IL23 Primary Antibody for IHC (fro), WB - ABIN2474990
Beun, van Eendenburg, Corver, van de Velde, Fleuren et al.: T-cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model. I. Significant bispecific lysis of syngeneic colon carcinoma CC531 is critically dependent on prolonged ... in Journal of immunotherapy : official journal of the Society for Biological Therapy 1992
Show all 4 Pubmed References
Human Polyclonal IL23 Primary Antibody for WB - ABIN2474991
Langrish, McKenzie, Wilson, de Waal Malefyt, Kastelein, Cua: IL-12 and IL-23: master regulators of innate and adaptive immunity. in Immunological reviews 2004
Show all 4 Pubmed References
Blocking IL-1 (show IL1A Antibodies) with IL-37 alleviates the symptoms in patients with inflammatory diseases including arteriosclerosis. The impact of IL-37 on inflammatory cytokines mediating atherosclerosis is beneficial and protective.
The serum levels of IL-37, which were correlated with antibody production and the serum levels of total IL-18 (show IL18 Antibodies) and IL-18BP (show IL18BP Antibodies), were elevated in the patients with primary Sjogren's syndrome.
this study shows that human IL-37 inhibited LPS (show IRF6 Antibodies)-induced mouse osteoclast formation and bone resorption via inhibition of LPS (show IRF6 Antibodies)-induced osteoclast related cytokines
serum IL-37 and its mRNA expression is increased in Ankylosing spondylitis (AS) patients with special consideration in patient with Osteoporosis and correlates with disease activity and BMD (show BEST1 Antibodies) which indicate that IL-37 may provide a novel research target for pathogenesis and therapy of AS.
IL-27 (show IL27 Antibodies) and IL-37 limit the induction of particular T cell subsets along with cytokine responses in S. stercoralis infections, which suggest the importance of IL-27 (show IL27 Antibodies) and IL-37 in immune modulation in a chronic helminth infection.
IL-37 regulates autophagy in SMMC-7721 and Huh-7 cells via inhibition of the PI3K (show PIK3CA Antibodies)/AKT (show AKT1 Antibodies)/mTOR (show FRAP1 Antibodies) signaling pathway.
IL37 itself reduced IL1beta (show IL1B Antibodies), IL6 (show IL6 Antibodies) and IL8 (show IL8 Antibodies) production in osteoarthritis chondrocytes, indicating that IL37 is able to induce a counter-regulatory anti-inflammatory feedback loop in chondrocytes. In addition, IL37 dampens catabolic enzyme expression.
The protein encoded by this gene is a member of the interleukin 1 cytokine family. This cytokine can bind to, and may be a ligand for interleukin 18 receptor (IL18R1/IL-1Rrp). This cytokine also binds to interleukin 18 binding protein (IL18BP), an inhibitory binding protein of interleukin 18 (IL18), and subsequently forms a complex with IL18 receptor beta subunit, and through which it inhibits the activity of IL18. This gene along with eight other interleukin 1 family genes form a cytokine gene cluster on chromosome 2. Five alternatively spliced transcript variants encoding distinct isoforms have been reported.
, IL-1 zeta
, IL-1F7b (IL-1H4, IL-1H, IL-1RP1)
, IL-1X protein
, IL1F7 (canonical product IL-1F7b)
, interleukin 1 family member 7
, interleukin 1, zeta
, interleukin-1 homolog 4
, interleukin-1 superfamily z
, interleukin-1-related protein